None listed
Conditions
Brief summary
This project involves consumption of two mixtures of herbs and spices by overweight and obese subjects for a period of six months. Body composition, body weight, blood pressure and blood lipid levels of the subjects were measured throughout the study (baseline, 3 months and at 6 months) to investigate the effects of the mixtures on these health outcomes.
Interventions
Capsules containing culinary herbs and spices were provided to participants. One group received high ACE-inhibitory herb and spice capsules (containing powdered amla (Emblica officinalis), cinnamon (Cinnamomun verum), cloves (Syzygium aromaticum), and oregano (Origanum vulgare)). Each capsule contained 600 mg of the herb spice mix powder. The high ACE-inhibitory group were instructed to take one capsule with water at meal times, three times per day (equates 1,800 mg herb spice mix per day). T
Capsules containing culinary herbs and spices were provided to participants. One group received high ACE-inhibitory herb and spice capsules (containing powdered amla (Emblica officinalis), cinnamon (Cinnamomun verum), cloves (Syzygium aromaticum), and oregano (Origanum vulgare)). Each capsule contained 600 mg of the herb spice mix powder. The high ACE-inhibitory group were instructed to take one capsule with water at meal times, three times per day (equates 1,800 mg herb spice mix per day). The intervention was for a 6 month period. Capsule containers with any remaining capsules were returned upon completion of the trial, to check for adherence.
Sponsors
La Trobe University
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
Participants were checked against eligibility criteria before inclusion in the study. Inclusion criteria included: a good understanding of English, aged between 18 and 65 years, a BMI greater than 25.
Exclusion criteria
Exclusion criteria included: pregnant women and people taking prescription medications. There was no upper BMI limit. Only data from participants who completed the 6 month intervention study was analysed.
Outcome results
None listed